-- Netflix (NFLX) 第一季度業績年增，但這家串流媒體巨頭對第二季的預期低於華爾街的預期。 每股收益從去年同期的 0.66 美元增至 1.23 美元。營收成長 16% 至 122.5 億美元，高於 FactSet 預測的 121.8 億美元。 Netflix 在致股東的信中表示，會員成長強於預期、價格上漲以及廣告收入增加共同推動了營收成長。 Wedbush Securities 先前預計這家串流媒體巨頭的營收將超出預期，並表示最新一輪的價格上漲可能會提振 Netflix 今年的獲利能力。 上個月，該公司提高了其在美國的所有套餐價格，包括將廣告支援的標準套餐價格提高至每月 8.99 美元。 Netflix預計第二季營收年增13.5%至125.7億美元，低於分析師預期的126.4億美元。每股盈餘預計為0.78美元，低於市場普遍預期的0.84美元。 Netflix預計本季營業利潤率將從去年同期的34.1%降至32.6%。 盤後交易中，Netflix股價下跌8%。 該公司表示：“正如我們在上季度信函中所述，由於新片上線時間的影響，內容攤銷的增長將主要集中在上半年。我們預計（第二季度）將實現2026年以來最高的同比增長率，之後增速將在下半年放緩至中高個位數。” Netflix 預計 2026 年營收將在 507 億美元至 517 億美元之間，年增率為 12% 至 14%。市場普遍預期為 513.7 億美元。 上週，Wedbush 將 Netflix 的目標股價從 115 美元上調至 118 美元，理由是廣告收入的顯著成長將推動 2026 年營收成長。 Wedbush 分析師 Alicia Reese 在周五發布的報告中寫道：“Netflix 應該能夠通過拓展合作夥伴關係、改進定向投放、利用人工智能以及增加更多直播內容，繼續從廣告業務中逐步獲益。” Netflix 表示，其聯合創始人兼董事長 Reed Hastings 將不會在 6 月任期屆滿後競選連任。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB